Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macias D, Méndez-Del-Barrio C, Periñán-Tocino T, Tejera-Parrado C, Vargas-González L, Diez-Fairen M, Alvarez I, Tartari JP, Buongiorno M, Aguilar M, Gorostidi A, Bergareche JA, Mondragon E, Vinagre-Aragon A, Croitoru I, Ruiz-Martínez J, Dols-Icardo O, Kulisevsky J, Marín-Lahoz J, Pagonabarraga J, Pascual-Sedano B, Ezquerra M, Cámara A, Compta Y, Fernández M, Fernández-Santiago R, Muñoz E, Tolosa E, Valldeoriola F, Gonzalez-Aramburu I, Sanchez Rodriguez A, Sierra M, Menéndez-González M, Blazquez M, Garcia C, Suarez-San Martin E, García-Ruiz P, Martínez-Castrillo JC, Vela-Desojo L, Ruz C, Barrero FJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Cerdan D, Tabernero C, Gomez Heredia MJ, Perez Errazquin F, Romero-Acebal M, Feliz C, Lopez-Sendon JL, Mata M, Martínez Torres I, Kim JJ, Dalgard CL, American Genome Center, Brooks J, Saez-Atienzar S, Gibbs JR, Jorda R, Botia JA, Bonet-Ponce L, Morrison KE, Clarke C, Tan M, Morris H, Edsall C, Hernandez D, Simon-Sanchez J, Nalls MA, Scholz SW, Jimenez-Escrig A, Duarte J, Vives F, Duran R, Hoenicka J, Alvarez V, Infante J, Marti MJ, Clarimón J, López de Munain A, Pastor P, Mir P, Singleton A, International Parkinson Disease Genomics Consortium

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

Movement disorders : official journal of the Movement Disorder Society, 2019; ;

Fernández JG, Sánchez-González C, Bettmer J, Llopis J, Jakubowski N, Panne U, Montes-Bayón M

Quantitative assessment of the metabolic products of iron oxide nanoparticles to be used as iron supplements in cell cultures.

Analytica chimica acta, 2018; 1039; 24-30

Pinel-Ríos J, Madrid-Navarro CJ, Pérez-Navarro MJ, Campos-Arillo V, Mínguez-Castellanos A, Escamilla-Sevilla F

Inflammatory bowel disease and risk of Parkinson's disease.

Parkinsonism & related disorders, 2018; 57; 78-79

Kia DA, Sabir MS, Ahmed S, Trinh J, Bandres-Ciga S, International Parkinson's Disease Genomics Consortium

LRP10 in α-synucleinopathies.

The Lancet. Neurology, 2018; 17(12); 1032

Lopez Zuñiga MA, Andreo Jimenez J, Barrero Hernández FJ

When a stroke is not a stroke

EMERGENCIAS, 2018; 30; 136-137

Giampieri F, Quiles JL, Orantes-Bermejo FJ, Gasparrini M, Forbes-Hernandez TY, Sánchez-González C, Llopis J, Rivas-García L, Afrin S, Varela-López A, Cianciosi D, Reboredo-Rodriguez P, Fernández-Piñar CT, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Dzul Lopez L, Xiao J, Battino M

Are by-products from beeswax recycling process a new promising source of bioactive compounds with biomedical properties?

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018; 112; 126-133

Lopez-Chaves C, Soto-Alvaredo J, Montes-Bayon M, Bettmer J, Llopis J, Sanchez-Gonzalez C

Gold nanoparticles: Distribution, bioaccumulation and toxicity. In vitro and in vivo studies.

Nanomedicine : nanotechnology, biology, and medicine, 2018; 14(1); 1-12

López P, Castro A, Flórez M, Miranda K, Aranda P, Sánchez-González C, Llopis J, Arredondo M

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects.

Frontiers in genetics, 2018; 9; 175

Blauwendraat C, Bandrés-Ciga S, Singleton AB

Predicting progression in patients with Parkinson's disease.

The Lancet. Neurology, 2017; 16(11); 860-862

Morillas E, Gómez-Chacón B, Gallo M

Flavor and object recognition memory impairment induced by excitotoxic lesions of the perirhinal cortex.

Neurobiology of learning and memory, 2017; 144; 230-234

Bandrés-Ciga S, Ruz C, Barrero FJ, Escamilla-Sevilla F, Pelegrina J, Vives F, Duran R

Structural genomic variations and Parkinson's disease.

Minerva medica, 2017; 108(5); 438-447

Bandres-Ciga S, Cookson MR

Alpha-synuclein triggers T-cell response. Is Parkinson's disease an autoimmune disorder?

Movement disorders : official journal of the Movement Disorder Society, 2017; 32(9); 1327

Banegas I, Prieto I, Segarra AB, Vives F, de Gasparo M, Duran R, de Dios Luna J, Ramírez-Sánchez M

Bilateral distribution of enkephalinase activity in the medial prefrontal cortex differs between WKY and SHR rats unilaterally lesioned with 6-hydroxydopamine.

Progress in neuro-psychopharmacology & biological psychiatry, 2017; 75; 213-218

Sanchez-Gonzalez C, Moreno L, Lopez-Chaves C, Nebot E, Pietschmann P, Rodriguez-Nogales A, Galvez J, Montes-Bayon M, Sanz-Medel A, Llopis J

Effect of vanadium on calcium homeostasis, osteopontin mRNA expression, and bone microarchitecture in diabetic rats.

Metallomics : integrated biometal science, 2017; 9(3); 258-267

Bandrés-Ciga S, Price TR, Barrero FJ, Escamilla-Sevilla F, Pelegrina J, Arepalli S, Hernández D, Gutiérrez B, Cervilla J, Rivera M, Rivera A, Ding JH, Vives F, Nalls M, Singleton A, Durán R

Genome-wide assessment of Parkinson's disease in a Southern Spanish population.

Neurobiology of aging, 2016; 45; 213.e3-213.e9

Martín IT, Ávila Rdel M, Herrera MZ, Arregui G, Osorio-Ceballos JL, Rojas ES, Almansa ÁH, Arrebola JP, Rull JP, Hernández JE, Ramírez EL

Role of radiosurgery in the management of glomus tumors.

Head & neck, 2016; 38 Suppl 1; E798-804

Bandrés-Ciga S, Mencacci NE, Durán R, Barrero FJ, Escamilla-Sevilla F, Morgan S, Hehir J, Vives F, Hardy J, Pittman AM

Analysis of the genetic variability in Parkinson's disease from Southern Spain.

Neurobiology of aging, 2016; 37; 210.e1-210.e5

Antonio-Rubio I, Madrid-Navarro CJ, Salazar-López E, Pérez-Navarro MJ, Sáez-Zea C, Gómez-Milán E, Mínguez-Castellanos A, Escamilla-Sevilla F

Abnormal thermography in Parkinson's disease.

Parkinsonism & related disorders, 2015; 21(8); 852-7

Gómez-Garre P, Huertas-Fernández I, Cáceres-Redondo MT, Alonso-Canovas A, Bernal-Bernal I, Blanco-Ollero A, Bonilla-Toribio M, Burguera JA, Carballo M, Carrillo F, José Catalán-Alonso M, Escamilla-Sevilla F, Espinosa-Rosso R, Carmen Fernández-Moreno M, García-Caldentey J, García-Moreno JM, Giacometti-Silveira S, Gutiérrez-García J, Jesús-Maestre S, López-Valdés E, Martínez-Castrillo JC, Medialdea-Natera MP, Méndez-Lucena C, Mínguez-Castellanos A, Angel Moya M, Ochoa-Sepulveda JJ, Ojea T, Rodríguez N, Rubio-Agusti I, Sillero-Sánchez M, Del Val J, Vargas-González L, Mir P

Lack of validation of variants associated with cervical dystonia risk: a GWAS replication study.

Movement disorders : official journal of the Movement Disorder Society, 2014; 29(14); 1825-8

Gómez-Garre P, Huertas-Fernández I, Cáceres-Redondo MT, Alonso-Canovas A, Bernal-Bernal I, Blanco-Ollero A, Bonilla-Toribio M, Burguera JA, Carballo M, Carrillo F, Catalán-Alonso MJ, Escamilla-Sevilla F, Espinosa-Rosso R, Fernández-Moreno MC, García-Caldentey J, García-Moreno JM, García-Ruiz PJ, Giacometti-Silveira S, Gutiérrez-García J, Jesús S, López-Valdés E, Martínez-Castrillo JC, Martínez-Torres I, Medialdea-Natera MP, Méndez-Lucena C, Mínguez-Castellanos A, Moya M, Ochoa-Sepulveda JJ, Ojea T, Rodríguez N, Sillero-Sánchez M, Vargas-González L, Mir P

BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.

Movement disorders : official journal of the Movement Disorder Society, 2014; 29(8); 1083-6

Olivares A, Ruiz-Garcia G, Olivares G, Górriz JM, Ramirez J

Automatic determination of validity of input data used in ellipsoid fitting MARG calibration algorithms.

Sensors (Basel, Switzerland), 2013; 13(9); 11797-817

Benito-León J, Cubo E, Coronell C, ANIMO Study Group

Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study.

Movement disorders : official journal of the Movement Disorder Society, 2012; 27(2); 211-8

Sáez-Zea C, Escamilla Sevilla F, Pérez Navarro MJ, Ortega Moreno A, Carnero Pardo C, Mínguez Castellanos A.

Screening for cognitive Impairment and dementia in Parkinson´s disease using multivariate predictive models

MOVEMENT DISORDERS, 2012; 27;

Sáez-Zea C, Escamilla Sevilla F, Pérez Navarro MJ, Ortega Moreno A, Carnero Pardo C, Mínguez Castellanos A.

Olfactory dysfunction is associated with cognitive Impairment in Parkinson´s disease.

MOVEMENT DISORDERS, 2012; 27;

Olivares A, Ramírez J, Górriz JM, Olivares G, Damas M

Detection of (in)activity periods in human body motion using inertial sensors: a comparative study.

Sensors (Basel, Switzerland), 2012; 12(5); 5791-814

Becerra JL, Ojeda J, Corredera E, Ruiz Giménez J

Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

CNS drugs, 2011; 25 Suppl 1; 3-16

Valldeoriola F, Coronell C, Pont C, Buongiorno MT, Cámara A, Gaig C, Compta Y, ADHESON Study Group

Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson's disease: the ADHESON study.

European journal of neurology, 2011; 18(7); 980-7

Wächter T, Mínguez-Castellanos A, Valldeoriola F, Herzog J, Stoevelaar H

A tool to improve pre-selection for deep brain stimulation in patients with Parkinson's disease.

Journal of neurology, 2011; 258(4); 641-6

Romani R, Lehto H, Laakso A, Horcajadas A, Kivisaari R, von und zu Fraunberg M, Niemelä M, Rinne J, Hernesniemi J

Microsurgery for previously coiled aneurysms: experience with 81 patients.

Neurosurgery, 2011; 68(1); 140-53; discussion 153-4

Santiago-Ramajo S, Katati MJ, Pérez-García M, Arjona-Moron V

Evaluating the recovery of cognitive impairment in subarachnoid hemorrhage taking into consideration the practice effects.

Neurosurgery, 2010; 67(6); 1497-504; discussion 1504

Escamilla-Sevilla F, Minguez-Castellanos A

Deep-brain stimulation for Parkinson's disease.

The New England journal of medicine, 2010; 363(10); 987; author reply 988

Valldeoriola F, Regidor I, Mínguez-Castellanos A, Lezcano E, García-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Martí MJ, Martínez-Martín P, Relova L, Rumià J, Cámara A, Burguera JA, Linazasoro G, de Val JL, Obeso J, Rodríguez-Oroz MC, Tolosa E, Grupo ESpañol para el EStudio de la EStimulación PALidal en la DIStonía

Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study.

Journal of neurology, neurosurgery, and psychiatry, 2010; 81(1); 65-9

Rubio de la Torre E, Luzón-Toro B, Forte-Lago I, Minguez-Castellanos A, Ferrer I, Hilfiker S

Combined kinase inhibition modulates parkin inactivation.

Human molecular genetics, 2009; 18(5); 809-23

Martinez-Martin P, Tolosa E, Hernandez B, Badia X, ValidQUICK Study Group

Validation of the "QUICK" questionnaire--a tool for diagnosis of "wearing-off" in patients with Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 2008; 23(6); 830-6

Mínguez-Castellanos A, Escamilla-Sevilla F, Hotton GR, Toledo-Aral JJ, Ortega-Moreno A, Méndez-Ferrer S, Martín-Linares JM, Katati MJ, Mir P, Villadiego J, Meersmans M, Pérez-García M, Brooks DJ, Arjona V, López-Barneo J

Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.

Journal of neurology, neurosurgery, and psychiatry, 2007; 78(8); 825-31

Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG

Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

Neurology, 2007; 68(23); 2012-8

Katati MJ, Santiago-Ramajo S, Pérez-García M, Meersmans-Sánchez Jofré M, Vilar-Lopez R, Coín-Mejias MA, Caracuel-Romero A, Arjona-Moron V

Description of quality of life and its predictors in patients with aneurysmal subarachnoid hemorrhage.

Cerebrovascular diseases (Basel, Switzerland), 2007; 24(1); 66-73

Martí-Fàbregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, Puig M, Blanco M, Castellanos M, Millán M, Roquer J, Obach V, Maestre J

Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.

Cerebrovascular diseases (Basel, Switzerland), 2007; 23(2-3); 85-90

Título del proyecto: Pruebas autonómicas no invasivas en el diagnóstico precoz de la enfermedad de Parkinson.

Financiador: Instituto de Salud Carlos III

Nº Expediente: PI10/01819

Ejecución: 2011-2014

IP: ADOLFO MINGUEZ

Título del proyecto: Enfermedad de Parkinson, nutrición y Estimulación Cerebral Profunda

Financiador: CONSEJERÍA DE IGUALDAD, SALUD Y POLÍTICAS SOCIALES

Nº Expediente: IBS-294/05

Ejecución: 2006-2007

IP: FRANCISCO ESCAMILLA

Título del ensayo: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Investigate The Efficacy And Safety Of Mongersen (GED-0301) For The Treatment Of Adult And Adolescent Subjects With Active Crohn?s Disease.

Tipo de ensayo: ENSAYO CLINICO COMERCIAL

Financiador: CELGENE CORPORATION

Nº Expediente: 2015-001924-40

Ejecución: 2017-2017

IP: EDUARDO LEO CARNERERO

Título del ensayo: A Phase 2b, Multicenter, Randomized, Open-label Study to Investigate the Efficacy, Safety and Pharmacokinetics of Different Treatment Regimens of AL-335, Odalasvir, and Simeprevir in Treatment-naïve and Treatment-experienced Subjects With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 and 6 Infection Without Cirrhosis.

Tipo de ensayo: ENSAYO CLINICO COMERCIAL

Financiador: JANSSEN-CILAG INTERNATIONAL N.V.

Nº Expediente: 2015-004200-38

Ejecución: 2017-2018

IP: MANUEL ROMERO GOMEZ

Título del ensayo: Seguimiento a largo plazo de pacientes reclutados hace 10 años en el programa de fase II de Fingolimod en esclerosis múltiple que cursa con brotes.

Tipo de ensayo: ESTUDIO POSAUTORIZACION COMERCIAL

Financiador:

Nº Expediente: C-025-2014

Ejecución: 2014-2014

IP: OSCAR FERNANDEZ

Título del ensayo: “ESTUDIO FASE IB, ABIERTO, MULTICÉNTRICO, DE ESCALADA DE DOSIS Y DE EXPANSIÓN, DE UNA COMBINACIÓN ADMINISTRADA POR VÍA ORAL DE BKM120 MÁS MEK162, EN PACIENTES ADULTOS CON TUMORES SÓLIDOS AVANZADOS SELECCIONADOS”

Tipo de ensayo: ENSAYO CLINICO COMERCIAL

Financiador: NOVARTIS FARMACEUTICA, S.A.

Nº Expediente: 0351/12

Ejecución: 2013-2014

IP: LUIS PAZ-ARES

Título del ensayo: "Estudio de seguimiento a 3 años, multicéntrico, para evaluar la durabilidad de la respuesta virológica sostenida en pacientes con Hepatitis C crónica tratados con Alisporivir"

Tipo de ensayo: ENSAYO CLINICO COMERCIAL

Financiador: NOVARTIS FARMACEUTICA, S.A.

Nº Expediente: 2011-006131-38

Ejecución: 2012-2017

IP: MANUEL ROMERO GOMEZ